November 7, 2024
admin
Niva Bupa IPO GMP, Review, Subscription Status, allotment & listing details @ Chanakyanipothi.com
A legacy of 31 Years.
India`s Oldest Investment & IPO website.
Most Trusted by Investors across India.
Table of Contents
- GMP
- Reviews
- Subscription
- Allotment
Latest updates of Niva Bupa IPO Listing
Niva Bupa Health Insurance Company Ltd, formerly Max Bupa Health Insurance Company, on Wednesday said it has mobilised Rs 990 crore from anchor investors a day before its initial share-sale opening for public subscription. Foreign and domestic institutions who were allotted shares in the anchor round include Zulia Investments Pte, Amansa Holdings, A91 Emerging Fund II LLP, Morgan Stanley, Fidelity and Government Pension Fund Global.
What is the last GMP of Niva Bupa IPO?
For latest GMP, Click
Niva Bupa IPO SubscriptionsPrice Rs. ? Lot ? shares, Rs. ? Crore |
|||||
| QIB | B HNI X | S HNI X | NII X | RII X | Total X |
| Applications: ? / (?x) Amount wise Bids recd. Rs. ? Crore |
|||||
Who are the promoters of Niva Bupa IPO?
THE PROMOTERS OF THE COMPANY ARE BUPA SINGAPORE HOLDINGS PTE. LTD AND BUPA INVESTMENTS OVERSEAS LIMITED
What are the Objects of Niva Bupa IPO?
The Company proposes to utilise the Net Proceeds towards funding the following objects:
1.Funding incremental working capital requirements of our Company;
2.Funding capital expenditure of our Company; and 3.General corporate purposes.
What is the business of Niva Bupa?
Niva Bupa Health Insurance aims to achieve this purpose through its health insurance products and services that enable customers to navigate their healthcare journey, by providing them access to a holistic health ecosystem. According to the Redseer Report, it is one of India’s largest and fastest growing SAHI based on overall health GDPI of ₹54,944.28 million in Fiscal 2024.
From Fiscal 2022 to Fiscal 2024, its overall GWP grew at a CAGR of 41.27% and its GWP from retail health grew at a CAGR of 33.41%. Its growth in overall health GDPI from Fiscal 2022 to Fiscal 2024 of 41.37% is one of the highest growths among SAHIs, and is almost double of the industry’s average, which according to the Redseer Report, increased by 21.42% from Fiscal 2022 to Fiscal 2024.
As per the Redseer Report, it had a market share in the Indian SAHI market of 16.24%, 15.58% and 13.87% for Fiscals 2024, 2023, and 2022 respectively based on retail health GDPI.
It aims to create a health insurance platform of choice for customers in India. It offers its customers the ability to access a comprehensive health ecosystem and service capabilities via our ‘Niva Bupa Health’ mobile application and website, thereby offering them a holistic proposition. This application provides its customers access to a range of healthcare solutions including diagnostics, digital consultation, annual health check-ups and health education content
Its Promoters, Bupa Singapore Holdings Pte. Ltd. and Bupa Investments Overseas Limited, are members of the Bupa Group. Through its association with the Bupa Group, it has access to its international healthcare insurance experience. Established in 1947, the Bupa Group is an international healthcare organization serving over 50 million customers3 worldwide, as at December 31, 2023, as per the Redseer Report.
It had 14.73 million active lives insured as of March 31, 2024. It is strategically focused on the retail health market and its GWP from its retail health products was 68.47% of its overall GWP for Fiscal 2024. F
For more information, click : www.nivabupa.com
Niva Bupa IPO GMP, Particulars & Guidance
| Niva Bupa IPO Details | |
| IPO opens on | 7 November 2024 |
| IPO closes on | 11 November 2024 |
| Issue Type | Book Built Issue IPO |
| Issue Size | 297,297,297 Shares / Rs 2200 Crore |
| * Fresh Issue | 108,108,108 Shares / Rs 800 Crore |
| * Offer for Sale | 189,189,189 Sh /Rs 1400 Cr |
| Face Value per share: | Rs. 10 |
| Price Band | Rs.70-74 |
| Retail Discount | Rs 0 per share |
| Employee discount | Rs. 0 per share |
| Retail Lot Size | 200 Shares |
| Listing will at | BSE, NSE |
| Shares offered in Niva Bupa? |
Shares | Rs. in Crore |
| QIB (75 %) | 222972972 | 1650 |
| NII (15 %) | 44594594 | 330 |
| RII (10 %) | 29729729 | 220 |
| Employees | – | – |
| Total Shares | 297297297 | 2200 |
| Retail portion will be oversubscribed by | ? Forms. | |
| How to apply in Niva Bupa IPO? | Amount Rs. |
|
| Min Retail Application | 200 Shares | 14,800 |
| Max Retail Application | 2600 Shares | 192,400 |
| Small HNI (Min) application | 2800 Shares | 207,200 |
| Small HNI (Max) application | 13400 Shares | 991,600 |
| Big HNI Application | 13600 Shares | 1006,400 |
| What is the timetable of Niva Bupa IPO? | |
| IPO opens on | 7 November 2024 |
| IPO Closes on | 11 November 2024 |
| IPO Allotment on | 12 November 2024 |
| Unblocking of ASBA | 13 November 2024 |
| Credit of Shares | 13 November 2024 |
| Listing on | 14 November 2024 |
| Registered Office of Niva Bupa | |
| C-98, 1st Floor Lajpat Nagar, Part 1, South Delhi, New Delhi – 110 024, Delhi, India | |
| Who are the Lead Managers of Niva Bupa IPO? ICICI Securities Limited Morgan Stanley India Company Pvt ltd Kotak Mahindra Capital Company Ltd Axis Capital Ltd HDFC Bank Limited Motilal Oswal Investment Advisors Ltd |
|
| Registrar to IPO | |
| Kfin Technologies ltd |
| Niva Bupa IPO Financial & Analytical Ratios | ||||
| Year | Total Income | Net Profit | EPS | RoNW |
| Rs. in Cr | Rs.in Cr | Rs. | % | |
| 2021-22 | 2111 | (-) | (-) | (-) |
| 2022-23 | 3161 | 12.54 | 0.09 | 1.87 |
| 2023-24 | 4194 | 81.84 | 0.51 | 5.68 |
| Book Value of the Share on 31.03.2024 |
Rs. | 12.06 | ||
| BV after the FPO | Rs. | ? | ||
| Offer Price at Cap | Rs. | 74 | ||
| Niva Bupa IPO Ratio Analysis |
|
| Price /EPS | 145 |
| Price/BV | 6.14 |
| Price/BV after IPO | ? |
How Niva Bupa IPO compares with the Peers?
| As on date of DRHP | FV | Net | PE |
| Rs. | Profit | Ratio of | |
| Rs. In Cr | |||
| Niva Bupa | 10 | 82 | ? |
| Star Health Ins | 10 | 845 | 36.97 |
| ICICI Lombard | 10 | 1919 | 45.92 |
| New India Assu. | 5 | 1091 | 35.23 |
# This is only coverage of News related to Grey Market. We do not deal in grey market premium, nor we recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.
Niva Bupa IPO Review * by Paresh Gordhandas, CA & Research Analyst.
Size: ?
Financial Snapshot & Guidance:?
* Disclosure: ?
Quicklinks
Niva Bupa IPO GMP
Niva Bupa IPO GMP review subscription allotment listing
Niva Bupa IPO GMP today, Details, review, Subscription Status, allotment
Niva Bupa Anchor Investors Details
